Quantinuum (NASDAQ:QNT) Stock Price Target Lowered at Needham & Company LLC

Quantinuum (NASDAQ:QNT) had its price target lowered by Needham & Company LLC from $100.00 to $60.00 in a report released on Friday, Marketbeat reports. The brokerage currently has a buy rating on the stock.

A number of other equities analysts have also recently issued reports on QNT. Jefferies Financial Group set a $85.00 price objective on Quantinuum in a report on Wednesday, August 12th. Morgan Stanley upgraded Quantinuum from an “equal weight” rating to an “overweight” rating and decreased their target price for the stock from $78.00 to $62.00 in a research report on Thursday, October 15th. Rosenblatt Securities reissued a “buy” rating and set a $155.00 target price on shares of Quantinuum in a research note on Thursday, October 22nd. Sanford C. Bernstein restated a “hold” rating on shares of Quantinuum in a report on Wednesday, August 12th. Finally, Cantor Fitzgerald reduced their price target on shares of Quantinuum from $90.00 to $55.00 and set an “overweight” rating on the stock in a research note on Friday. Thirteen investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Quantinuum has a consensus rating of “Moderate Buy” and an average price target of $85.62.

Quantinuum Stock Up 26.0%

Shares of NASDAQ:QNT traded up $7.75 during trading hours on Friday, hitting $37.57. 5,036,156 shares of the company’s stock traded hands, compared to its average volume of 2,182,406. Quantinuum has a 1 year low of $28.31 and a 1 year high of $86.79. The firm has a fifty day simple moving average of $43.41. The firm has a market cap of $9.89 billion and a price-to-earnings ratio of -134.18.

Quantinuum (NASDAQ:QNT) last issued its quarterly earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share for the quarter, topping the consensus estimate of ($0.99) by $0.70. The business had revenue of $9.05 million during the quarter. On average, analysts predict that Quantinuum will post -4.76 EPS for the current year.

Hedge Funds Weigh In On Quantinuum

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. CoreCap Advisors LLC bought a new stake in shares of Quantinuum in the third quarter valued at about $32,000. Fifth Third Bancorp increased its position in Quantinuum by 1,530.2% during the 3rd quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock valued at $49,000 after purchasing an additional 964 shares during the period. IFP Advisors Inc raised its holdings in shares of Quantinuum by 1,150.0% in the 3rd quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock valued at $60,000 after purchasing an additional 1,150 shares in the last quarter. Russell Investments Group Ltd. bought a new stake in shares of Quantinuum in the 3rd quarter valued at about $97,000. Finally, Pier 88 Investment Partners LLC bought a new stake in shares of Quantinuum in the 3rd quarter valued at about $154,000.

Quantinuum News Summary

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
• Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
• Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
• Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results

Quantinuum Company Profile

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.